REN for Migraine - Remote Electrical Neuromodulation Designed with Teenagers in Mind

Migraine disease affects millions of adolescents in the US. Adherence to medications is often low due to disruptive side effects. With early and effective care, it is possible to avoid chronification and long-term negative consequences.
Learn how the Nerivio REN wearable can help: www.nerivio.com
INDICATIONS FOR USE
Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older. It is a prescription use, self administered device for use in the home environment at the onset of migraine headache or aura for acute treatment, or every other day for preventive treatment.
CONTRAINDICATIONS
Nerivio should not be used by people with uncontrolled epilepsy, an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device. Such use could cause electric shock, electrical interference or serious injuries or medical conditions.
IMPORTANT SAFETY INFORMATION
Nerivio has not been evaluated in people with congestive heart failure (CHF), severe cardiac or cerebrovascular disease, for pregnancy, or those under the age of 12. Nerivio should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions.
Nerivio is available by prescription only. As with any therapy, side effects may occur and treatment results can vary from person to person. If you have any questions, consult your physician. For full user instructions and safety information, please refer to the Nerivio User Manual at www.nerivio.com.
REFERENCES
1. Kabbouche MA, Gilman DK. Management of migraine in adolescents. Neuropsychiatr Dis Treat. 2008;4(3):535-548. doi:10.2147/ndt.s495
2. Charles, J.A., Peterlin, B.L., Rapoport, A.M. et al. Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. J Headache Pain 10, 227-233 (2009).
3. Freitag, F., & Schloemer, F. (2016, January). Recent developments in the treatment of migraine in children and adolescents. Journal of Headache & Pain Management, ISSN 2472-1913. DOI:10.4172/2472-1913.100009.
©2024 Theranica. All rights reserved.
"